Fate Therapeutics Lands $10,290,000 New Funding Round

  • Feed Type
  • Date
    8/24/2016
  • Company Name
    Fate Therapeutics
  • Mailing Address
    3535 General Atomics Court San Diego, CA 92121 USA
  • Company Description
    Better Cells for Better Therapies We combine a deep understanding of hematopoietic cell biology with an unmatched expertise in programming cell function and fate. We believe the biological properties of immune cells can be modulated outside the body to impart profound therapeutic effects inside the body upon their administration to a patient. We seek to… Read more
  • Website
    http://www.fatetherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,290,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy